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Transient and Sustained Bacterial Adaptation following Repeated
Sublethal Exposure to Microbicides and a Novel Human
Antimicrobial Peptide
Sarah Forbes,a Curtis B. Dobson,b Gavin J. Humphreys,a Andrew J. McBaina
Manchester Pharmacy Schoola and Faculty of Life Sciences,b The University of Manchester, Manchester, United Kingdom
Microbicides (biocides) play an important role in the prevention and treatment of infections. While there is currently little evidence for
in-use treatment failures attributable to acquired reductions in microbicide susceptibility, the susceptibility of some bacteria can be
reduced by sublethal laboratory exposure to certain agents. In this investigation, a range of environmental bacterial isolates (11 genera,
18 species) were repeatedly exposed to four microbicides (cetrimide, chlorhexidine, polyhexamethylene biguanide [PHMB], and tri-
closan) and a cationic apolipoprotein E-derived antimicrobial peptide (apoEdpL-W) using a previously validated exposure system.
Susceptibilities (MICs and minimum bactericidal concentrations [MBCs]) were determined before and after 10 passages (P10) in the
presence of an antimicrobial and then after a further 10 passages without an antimicrobial to determine the stability of any adapta-
tions. Bacteria exhibiting >4-fold increases in MBCs were further examined for alterations in biofilm-forming ability. Following mi-
crobicide exposure, >4-fold decreases in susceptibility (MIC or MBC) occurred for cetrimide (5/18 bacteria), apoEdpL-W (7/18), chlo-
rhexidine (8/18), PHMB (8/18), and triclosan (11/18). Of the 34 >4-fold increases in the MICs, 15 were fully reversible, 13 were
partially reversible, and 6 were nonreversible. Of the 26 >4-fold increases in the MBCs, 7 were fully reversible, 14 were partially revers-
ible, and 5 were nonreversible. Significant decreases in biofilm formation in P10 strains occurred for apoEdpL-W (1/18 bacteria), chlo-
rhexidine (1/18), and triclosan (2/18), while significant increases occurred for apoEdpL-W (1/18), triclosan (1/18), and chlorhexidine
(2/18). These data indicate that the stability of induced changes in microbicide susceptibility varies but may be sustained for some com-
binations of a bacterium and a microbicide.
Microbicides have been used for more than a century to controlmicrobial growth in thedomiciliary, clinical, and industrial en-
vironments (1–4). The modes of action of cationic agents, such as
quaternary ammoniumcompounds (QACs) (e.g., cetrimide) andbi-
guanides (e.g., chlorhexidine andpolyhexamethylenebiguanide), are
believed to rely largelyon interactionswith thebacterial cell envelope,
leading tomembranedisruptionand the leakageof cytoplasmic com-
ponents (5). Microbicides may also interact with specific pharmaco-
logical targets, such as the enoyl-acyl carrier protein reductase FabI,
which is a major target of triclosan (1, 6).
Microbicidal compounds are used for a range of applications, in-
cluding clinical antisepsis and disinfection (2, 4) and the control of
biofouling and contamination in industry (7, 8) and in food produc-
tion (9, 10), while in the domestic setting, they have been incorpo-
rated as hygienic adjuncts into various products, including hand
washes (11) andhard surface disinfectants (12). There is also increas-
ing interest in their incorporation into medical devices such as uri-
nary catheters (2) and surgical dressings (4) with the intention of
inhibiting bacterial colonization and biofilm formation (13–16).
Despite the demonstrable benefits of microbicides in some ap-
plications (2, 17–20), concerns have been raised that their exten-
sive use may select for bacteria with reduced susceptibility (21–
23). This could occur through the selection of target site-adapted
mutants (6) or reversibly through induced phenotypic adaptation
(24). While bacterial insusceptibility to in-use concentrations of
microbicides is apparently uncommon, there is some evidence of
bacteria surviving an antimicrobial challenge, for instance, in mi-
crobicide-containing solutions (25), leading to product contami-
nation-related outbreaks (26). It is, however, important to note
when considering such reports that microbicides exhibit a spec-
trum of activity and that some microorganisms may be nonsus-
ceptible without prior microbicide exposure (27). It is therefore
possible that in some cases sublethal microbicide exposure could
result in the clonal expansion of preexisting bacterial populations
with comparatively lower intrinsic susceptibilities, rather than the
clonal selection of resistance (28).
While induced changes in antimicrobial susceptibility have
been reported in laboratory studies through the exposure of bac-
teria to sublethal concentrations of microbicides (24, 29, 30),
there are very few reports in the literature that document the sta-
bility of such changes or that compare the selective potential of
multiple microbicides against a range of taxonomically diverse
bacteria. We have therefore assessed the potential changes in sus-
ceptibility for multiple bacteria after repeated exposure to the mi-
crobicides cetrimide, chlorhexidine, polyhexamethylene bigua-
nide (PHMB), and triclosan and a novel human apolipoprotein
E-derived antimicrobial peptide (apoEdpL-W). Additionally,
since previous investigations have indicated that microbicide (30)
and antibiotic (31) adaptations may result in alterations in bio-
film-forming ability, the influence of sublethal microbicide expo-
sure on bacterial biofilm formation was also evaluated.
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MATERIALS AND METHODS
Bacteria. Pseudomonas aeruginosa ATCC 9027, Staphylococcus aureus
ATCC 6538, and Serratia marcescens ATCC 13880 were obtained from
Oxoid (Basingstoke, UnitedKingdom).Burkholderia cepaciaATCCBAA-
245,Escherichia coliATCC25922, andKlebsiella pneumoniaeATCC13883
were obtained from the Leibniz Institute DSMZ-German Collection of
Microorganisms and Cell Cultures (Braunschweig, Germany). Micrococ-
cus luteus MRBG 9.25, Staphylococcus caprae MRBG 9.3, Staphylococcus
capitis MRBG 9.34, Staphylococcus lugdunensis MRBG 9.36, Staphylococ-
cus warneri MRBG 9.27, Staphylococcus epidermidis MRBG 9.33, and
Staphylococcus haemolyticusMRBG9.35were previously isolated from the
axillae of three healthy male volunteers (23). Bacillus cereus MRBG 4.21,
Stenotrophomonas maltophilia MRBG 4.17, and Chryseobacterium indolo-
genes MRBG 4.29 were isolated from a domestic kitchen drain biofilm
(28). Enterococcus faecalis WIBG 1.1 and Corynebacterium xerosis WIBG
1.2 were wild-type wound isolates provided by Angela Oates, The Univer-
sity of Manchester.
Chemical reagents and bacterial growth media.Triclosan, cetrimide,
and chlorhexidine were purchased from Sigma-Aldrich (Dorset, United
Kingdom). Vantocil (a 20% aqueous solution of PHMB) was obtained
fromArchChemicals, Inc. (Manchester, UnitedKingdom). Peptideswere
purchased fromAlta Bioscience (West Midlands, United Kingdom), hav-
ing been synthesized using 9-fluorenylmethyl carbamate chemistry and
purified by high-performance liquid chromatography. Bacteriological
media were purchased fromOxoid. All other chemical reagents were pur-
chased from Sigma-Aldrich unless otherwise stated. Bacterial growthme-
dia were sterilized at 121°C and 15 lb/in2 for 15 min prior to use. All
bacteria were cultured on Mueller-Hinton agar (Oxoid) and incubated
aerobically at 37°C for 18 h unless stated otherwise.
Determination of bacterial MICs and MBCs. The MICs were deter-
mined using the microdilution method as described previously (23, 32).
Briefly, overnight bacterial cultures were adjusted to an optical density at
600 nm (OD600) of 0.8 and diluted 1:100 in Mueller-Hinton broth in a
96-well microtiter plate containing doubling dilutions of the relevant mi-
crobicide. All microbicide stock solutions were prepared at 5 times the
highest test concentration in water and filter sterilized (0.22 M). The
plates were incubated at 37°C (24 h) with agitation (100 rpm). The MIC
was defined as the lowest concentration forwhich bacterial growth did not
occur. Growth was viewed as turbidity (600 nm) in comparison to that of
an uninoculated well (negative control) and was detected using a micro-
titer plate reader (PowerWave XS; BioTek, Bedfordshire, United King-
dom). Aliquots (10l) fromwells exhibiting no turbiditywere transferred
to sterile Mueller-Hinton agar and incubated (37°C) for the determina-
tion of the minimum bactericidal concentration (MBC). The MBC was
defined as the lowest concentration of microbicide at which no growth
occurred after 4 days of incubation.
Biofilm formation assay. Overnight cultures of test bacteria were ad-
justed to an OD600 of 0.8 then diluted 1:100 in sterile Mueller-Hinton
broth. A volume of 150 l of diluted bacterial inoculum was delivered to
each test well of a 96-well microtiter plate. Plates were incubated for 48 h
at 37°C and 20 rpm to promote biofilm growth. Wells were washed twice
with 250 l of sterile phosphate-buffered saline (PBS) before 200 l of
0.5% (wt/vol) crystal violet solution was added to the test wells. Plates
were incubated for 30 min at room temperature, and the wells were sub-
sequently washed twice with 250 l of PBS and left to dry at room tem-
perature for 1 h. The attached crystal violet was solubilized in 250 l of
95% ethanol per well, and plates were agitated at room temperature at 20
rpm for 1 h. After solubilization, biofilm growth was viewed as the change
in OD600 relative to that in a sterile negative control (33). Biofilm-bound
crystal violet was quantified for P0 and P10 bacteria, and average values
were calculated using data from two separate experiments, eachwith three
technical replicates (n  6). Statistical significance was determined using
a paired Student’s t test (P  0.001).
Exposure of bacteria to sublethal concentrations of microbicides. A
previously validated system (23) was used to generate reproducible ca.
100-fold antimicrobial concentration gradients on Mueller-Hinton agar
plates using a spiral plater (Whitley automated spiral plater; DonWhitley
Scientific, Shipley, United Kingdom). The initial antimicrobial stock so-
lutions (50 l) were deposited on the agar surface. Plates were dried for 1
h at room temperature prior to radial deposition of bacterial pure cultures
and then incubated (4 days at 37°C) in a static aerobic incubator. After
incubation, growth observed at the highest microbicide concentration
was aseptically removed and radially streaked onto a fresh plate contain-
ing the same antimicrobial concentration gradient. If growth was ob-
served across the whole antimicrobial gradient, a new plate containing a
5 higher stock solution concentration was used (30). This process was
repeated until 10 passages had occurred. Bacteria were then passaged a
further 10 times in the absence of any antimicrobial (X10). Bacteria at P0,
P10, and X10 were archived for subsequent MIC and MBC testing.
RESULTS
Cetrimide. The majority of the test bacteria in this study under-
went comparatively minor reductions (2-fold) in susceptibility
following repeated exposure to cetrimide (Table 1). From those
that underwent a 4-fold decrease, three of the five strains were
staphylococci, with theMICs increasing by in excess of 18-fold for
S. haemolyticus. Following the cessation of microbicide exposure,
full reversions in the MICs occurred for E. coli, K. pneumoniae,
and S. epidermidis, while no reversion in the MICs was apparent
for S. haemolyticus and S. lugdunensis. E. coli was the only bacte-
rium to display a 4-fold increase in the MBC, which completely
reverted when grown in the absence of cetrimide.
Chlorhexidine.Data in Table 2 indicate that4-fold increases
in the MICs occurred for B. cepacia, E. faecalis, K. pneumoniae, S.
marcescens, S. lugdunensis, and S. maltophilia following 10 pas-
sages in the presence of chlorhexidine. E. faecalis demonstrated a
complete reversion in the MIC after the cessation of microbicide
exposure. Partial reversions (MICs) were observed for B. cepacia
and S. marcescens, while K. pneumoniae, S. maltophilia, and S.
lugdunensis values failed to revert when passaged in the absence of
chlorhexidine. Partial reversions in MBCs were observed in B.
cereus, B. cepacia, S. marcescens, and S. aureus, while S. lugdunensis
and S. maltophilia did not revert significantly after growth in a
microbicide-free environment.
PHMB. After 10 passages in the presence of PHMB, 4-fold
increases in theMICs were observed for C. indologenes, E. faecalis,
K. pneumoniae, M. luteus, S. capitis, and S. caprae (Table 3). C.
indologenes, E. faecalis, and S. capitis also showed 4-fold in-
creases in the MBCs, as did S. lugdunensis. Following 10 passages
in the absence of PHMB, the MICs partially reverted to within a
2-fold difference from preexposure levels, with the exception of
E. faecalis, which only partially reverted. Similarly, all test bacteria
yielded X10MBC values within a 2-fold difference from preexpo-
sure values, with the exception of C. indologenes (a 4-fold differ-
ence). Of note, B. cepacia, B. cereus, C. xerosis, and S. marcescens
exhibited X10MIC/MBC values that weremoderately lower (3-
fold) than those determined prior to microbicide exposure.
Triclosan. Eleven out of 18 test bacteria underwent a 4-fold
increase in theMICs, and 9 out of 18 exhibited a 4-fold increase
in the MBCs following 10 passages in the presence of triclosan
(Table 4). The bacteriummost susceptible to triclosan (MIC) was
S. aureus. However, this bacterium also underwent the greatest
reduction in susceptibility (MIC) following repeated sublethal
microbicide exposure. In terms of the MBCs, E. coli was the most
susceptible bacterium, followed by S. aureus and E. faecalis. Inter-
estingly, these bacteria also exhibited the most pronounced
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changes in the MBCs during the investigation, with a 58-fold in-
crease observed in the case of E. coli. P. aeruginosawas shown to be
intrinsically nonsusceptible to all test concentrations of triclosan
(27). After repeated cycles of growth in a triclosan-free medium,
the MICs of the majority (8/11) of test bacteria reverted to preex-
posure levelswith the exception of those forE. coli,K. pneumoniae,
and S. aureus, which remained elevated.With regard to theMBCs,
E. faecalis, E. coli, and S. aureus only partial reverted to preexpo-
sure values. The remaining test bacteria yielded MBCs compara-
ble to preexposure levels following the cessation of triclosan dos-
ing (X10) (Table 4).
ApoEdpL-W. ApoEdpL-W was most potent against S. caprae
and S. epidermidis, followed by S. warneri and C. indologenes. S.
marcescens was the least susceptible of the test bacteria to the pep-
tide (Table 5). With respect to changes in susceptibility following
antimicrobial exposure, S. caprae exhibited the largest decrease in
apoEdpL-W susceptibility after 10 passages, with the MIC value
increasing by up to 21-fold (P10). After growth in peptide-free
medium (X10), markedly increased MIC/MBC values (4-fold)
partially reverted for a number of test bacteria, including C. in-
dologenes, S. caprae, and K. pneumoniae. Changes in sensitivities
(MBCs) for S. epidermidis and S. haemolyticuswere stable, with no
reversion in susceptibility being detected following 10 passages in
the absence of the peptide.
TABLE 1MICs and minimum bactericidal concentrations of bacteria before and after treatment with cetrimidea
Test bacterium
MIC (g/ml) MBC (g/ml)
Before exposure P10 X10 Before exposure P10 X10
Bacillus cereus 7.3 14.5 7.3 14.5 48.3 (8) 29
Burkholderia cepacia 38.7 (17) 38.6 (8) 29 116 232 232
Chryseobacterium indologenes 12.1 (4) 14.5 14.5 29 29 29
Corynebacterium xerosis 3.6 3.6 3.6 14.5 9.7 (4) 14.5
Enterococcus faecalis 12.1 (4) 14.5 14.5 29 38.7 (16) 58
Escherichia coli 29.17 (8) 116 29 116 464 116
Klebsiella pneumoniae 29.3 (8) 116 29 29 58 58
Micrococcus luteus 14.5 7.3 (33) 14.5 58 19.3 (8) 29
Pseudomonas aeruginosa 232 232 232 464 464 464
Serratia marcescens 24.2 (8) 37.3 (14) 29 37.3 (14) 116 58
Staphylococcus aureus 4.8 (2) 6 (2) 7.3 7.3 14.5 7.3
Staphylococcus capitis 3.6 7.3 7.3 14.5 7.3 7.3
Staphylococcus caprae 0.9 1.8 1.8 14.5 14.5 14.5
Staphylococcus epidermidis 1.8 7.3 1.8 3.6 7.3 7.3
Staphylococcus haemolyticus 0.4 7.3 7.3 14.5 14.5 14.5
Staphylococcus lugdunensis 0.4 3.6 3.6 29 14.5 29
Staphylococcus warneri 4.8 (2) 6.1 (2) 7.3 193.3 232 116
Stenotrophomonas maltophilia 19.3 (8) 29 29 58 24.2 (8) 58
a Data show the mean MICs and minimum bactericidal concentrations of bacteria before and after microbicide exposure in g/ml and represent samples taken from two separate
experiments each with three technical replicates. For data that varied between replicates, SDs are given in parentheses. Bold type indicates a 4-fold change when comparing P0 to
P10 and X10 values.
TABLE 2MICs and minimum bactericidal concentrations of bacteria before and after treatment with chlorhexidinea
Test bacterium
MIC (g/ml) MBC (g/ml)
Before exposure P10 X10 Before exposure P10 X10
Bacillus cereus 14.5 14.5 14.5 29 232 116
Burkholderia cepacia 3.6 29 7.3 26.6 (6) 232 116
Chryseobacterium indologenes 7.3 7.3 7.3 7.3 14.5 7.3
Corynebacterium xerosis 3.3 (1) 3.6 3.6 21.8 (8) 14.5 14.5
Enterococcus faecalis 3.6 24.2 (8) 3.6 26.6 (6) 58 29
Escherichia coli 6.7 (1) 7.3 7.3 13.3 (3) 29 29
Klebsiella pneumoniae 2.1 (1) 14.5 14.5 16.3 (5) 58 116
Micrococcus luteus 3.6 3.6 3.6 14.5 7.3 14.5
Pseudomonas aeruginosa 7.3 14.5 7.3 14.5 29 14.5
Serratia marcescens 12.1 (4) 116 58 24.2 (7) 232 116
Staphylococcus aureus 8.5 (4) 3.6 3.6 13.3 (4) 58 29
Staphylococcus capitis 3.6 6 (2) 7.3 14.5 14.5 29
Staphylococcus caprae 3.6 3.6 7.3 29 29 29
Staphylococcus epidermidis 13.3 (3) 9.7 (4) 14.5 33.8 (12) 24.2(8) 29
Staphylococcus haemolyticus 1.4 (0.4) 3 (1) 1.8 4.2(1) 14.5 7.3
Staphylococcus lugdunensis 0.9 3.6 4.8 (2) 1.7 (0.3) 48.3 (17) 58
Staphylococcus warneri 29 29 29 58 58 58
Stenotrophomonas maltophilia 4.8 (2) 29 29 14.5 58 58
a See Table 1 footnote for explanation of data.
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Changes in biofilm formation in antimicrobial-insuscepti-
ble microorganisms. Bacteria that had undergone 4-fold
changes in the MBCs during the training procedure were further
assessed for changes in their ability to form biofilms. The follow-
ing bacteria exhibited a significant decrease in biofilm formation
in a microtiter plate-based system: E. faecalis following exposure
to apoEdpL-W, B. cepacia following exposure to chlorhexidine,
and S. aureus and S. lugdunensis following exposure to triclosan.
In contrast, repeated exposures of E. coli and S. epidermidis to
triclosan and apoEdpL-W appeared to promote biofilm forma-
tion (Fig. 1), while chlorhexidine exposure was associated with
increases in biofilm formation in K. pneumoniae and S. marc-
escens. For PHMB, no significant difference in biofilm formation
was observed between the unexposed and exposed counterparts.
In addition, none of the microorganisms investigated showed a
4-fold change in the MBC toward cetrimide, and they were
therefore not examined for changes in biofilm formation.
DISCUSSION
In agreement with previous in vitro studies (23, 24, 29, 34), re-
peated laboratory exposure of certain bacteria to microbicides re-
sulted in decreases in bacterial susceptibility. Of the 34 4-fold
decreases in susceptibility (MICs) observed in this study, 15 were
fully reversible, 13 were partially reversible, and 6 were nonrevers-
TABLE 3MICs and minimum bactericidal concentrations of bacteria before and after treatment with polyhexamethylene biguanidea
Test bacterium
MIC (g/ml) MBC (g/ml)
Before exposure P10 X10 Before exposure P10 X10
Bacillus cereus 58 29 58 58 58 58
Burkholderia cepacia 58 58 29 116 58 58
Chryseobacterium indologenes 0.9 3.6 1.8 1.8 14.5 7.3
Corynebacterium xerosis 2.7 (1) 7.3 2.2 (0.4) 21.8 (8) 7.3 14.5
Enterococcus faecalis 1.8 14.5 9.7 7.3 29 7.3
Escherichia coli 13.3 (3) 24.2 (8) 7.3 26.6 (6) 58 14.5
Klebsiella pneumoniae 7.3 29 9.7 (4) 29 96.7 (34) 58
Micrococcus luteus 1.8 7.3 1.8 7.3 14.5 7.3
Pseudomonas aeruginosa 31.3 (6) 58 29 116 232 116
Serratia marcescens 38.7 (15) 29 29 38.7 (15) 29 29
Staphylococcus aureus 7.3 7.3 7.3 52 (11) 58 58
Staphylococcus capitis 1.1 (0.3) 6 (2) 1.8 7.3 48.3 (17) 7.3
Staphylococcus caprae 6.7 (2) 4.9 (2) 7.3 29 38.7 (17) 29
Staphylococcus epidermidis 3 (1) 14.5 3.6 26.6 (6) 38.7 (17) 29
Staphylococcus haemolyticus 1.8 7.3 1.8 29 58 29
Staphylococcus lugdunensis 3.6 7.3 1.8 5.4 (2) 48.3 (17) 7.3
Staphylococcus warneri 3.6 6 (2) 3.6 29 58 29
Stenotrophomonas maltophilia 3 (1) 3.6 3.6 29 29 29
a See Table 1 footnote for explanation of data.
TABLE 4MICs and minimum bactericidal concentrations of bacteria before and after treatment with triclosana
Test bacterium
MIC (g/ml) MBC (g/ml)
Before exposure P10 X10 Before exposure P10 X10
Bacillus cereus 7.3 29 7.3 58 116 58
Burkholderia cepacia 232 116 232 464 464 464
Chryseobacterium indologenes 0.9 3.6 0.9 3.6 7.3 3.6
Corynebacterium xerosis 7.3 58 7.3 7.3 58 7.3
Enterococcus faecalis 3.3 (1) 58 3.3 (1) 3.3 (1) 96.7 (34) 14.5
Escherichia coli 0.5 29 4.82 0.5 29 14.5
Klebsiella pneumoniae 0.9 116 14.5 29 116 14.5
Micrococcus luteus 7.3 12.1 (4) 3.63 7.3 14.5 7.3
Pseudomonas aeruginosa NSb NS NS NS NS NS
Serratia marcescens 232 116 232 232 464 232
Staphylococcus aureus 0.2 29 2.4 1.8 58 12.1 (4)
Staphylococcus capitis 24.2 (8) 29 14.5 29 77.3 (33) 29
Staphylococcus caprae 12.3 (4) 29 14.5 24.2 (8) 58 29
Staphylococcus epidermidis 13.3(3) 38.7 (17) 14.5 53.2 (12) 116 58
Staphylococcus haemolyticus 0.4 29 0.4 7.3 58 7.3
Staphylococcus lugdunensis 0.9 29 0.9 7.3 58 7.3
Staphylococcus warneri 0.9 24.2 (8) 0.9 14.5 38.7 (17) 14.5
Stenotrophomonas maltophilia 14.5 232 14.5 58 463 48.3
a See Table 1 footnote for explanation of data.
b NS, nonsusceptible (MIC/MBC ratio of 1,000 g/ml).
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ible. Of the 26 4-fold increases in theMBCs, 7 were fully revers-
ible, 14were partially reversible, and 5were nonreversible. Readily
reversible changes in susceptibility may result from temporary
phenotypic adaptations, such as the induction of stress responses
(35, 36) and changes in envelope composition (37) or efflux pump
expression (22, 38, 39). In contrast, the reductions in antimicro-
bial susceptibility that were maintained after growth in the ab-
sence of the antimicrobial may be attributable to the selection of
mutants (6).
While there are multiple reports in the literature of the labora-
tory generation of bacteria with decreased susceptibilities toward
microbicides, adapted bacteria may remain effectively susceptible
to in-use concentrations of the agent. For example, in the current
investigation, the largest decrease inmicrobicide susceptibility oc-
curred for S. aureus in response to triclosan, exhibiting a 45-fold
increase in theMIC (0.2g/ml to 29g/ml) and a 32-fold increase
in theMBC (1.8g/ml to 58g/ml) (Table 4); however, the in-use
triclosan concentration, for example, in hand soaps is approxi-
mately 3,000g/ml, which is orders of magnitude higher than the
observed elevatedMIC andMBC (40, 41). Similarly, out of all the
decreases in microbicide susceptibility observed in this investiga-
tion, no bacterium exhibited either an induced increase in the
MIC/MBC or the wild-type MIC/MBC above in-use microbicide
concentrations. The only bacterium which was nonsusceptible
was P. aeruginosa toward triclosan; this intrinsic characteristic is
not inducible andhad previously been attributed to the expression
of efflux pumps (41–43).
Bacterial susceptibility to antimicrobial agents can be mark-
edly influenced by structural variations in the bacterial cell enve-
lope which affect cell permeability (44–46). Barriers to microbi-
cide cell penetration, such as the additional outer membrane in
Gram-negative bacteria (47) or the presence of a spore coat in
bacterial endospores (48), can confer protection against microbi-
cides and possibly account for some of the low microbicide sus-
ceptibilities observed in these respective groups of bacteria in the
current study. In Gram-positive bacteria, compounds such as
QACs and biguanides may readily transverse the cell wall, making
the bacteria relatively susceptible to these compounds (49, 50).
However, as is apparent in the current investigation, susceptibility
can range widely within each bacterial group. When challenged
with a microbicide, a reduction in microbicide accumulation in
the bacterial cell is a common survival mechanism and may be
partly achieved by decreased cell permeability. The effectiveness of
this strategy depends on several factors relating to the particular
bacterium and the microbicide.
While triclosan induced the highest frequency and largestmag-
nitude of changes in bacterial susceptibility and cetrimide expo-
sure resulted in the lowest, all changes in the MICs and MBCs
toward triclosan were either fully or partially reversible. The lab-
oratory selection of bacteria with reduced susceptibility toward
triclosan has been previously documented and has been attributed
tomutations in the enoyl-acyl carrier reductase encoded by fabI or
the overexpression of efflux pumps (6, 51). For example, reduced
triclosan susceptibility in E. coli has been generated in the labora-
tory by the selection of bacteria with mutations in fabI or through
the upregulation of the multidrug efflux pump AcrAB or its pos-
itive regulators, MarA and SoxS (51–53). Similarly, in another
laboratory-based investigation, the exposure of S. maltophilia to
triclosan selected for insusceptible variants that overexpress the
SmeDEFmultidrug efflux pump (39), whilemutations in fabI in S.
aureus have also been shown to reduce triclosan susceptibility
(54).
The quaternary ammonium compound cetrimide and bigua-
nides, such as PHMB and chlorhexidine, reportedly target the
bacterial cytoplasmicmembrane (1, 45, 47, 55) and the expression
of multidrug resistance efflux pumps can influence bacterial sus-
ceptibility towards these agents (38; previously reviewed in refer-
ence 56). The plasmid-encoded OqxAB multidrug resistance
pump reportedly conferred a decrease in cetrimide susceptibility
in E. coli (57), and overexpression of the major facilitator super-
family efflux pump NorA in S. aureus has also been linked to
reduced cetrimide susceptibility (58). In the present study, tran-
TABLE 5MICs and minimum bactericidal concentrations of bacteria before and after treatment with apoEdpL-Wa
Test bacterium
MIC (g/ml) MBC (g/ml)
Before exposure P10 X10 Before exposure P10 X10
Bacillus cereus 14.5 29 29 58 58 58
Burkholderia cepacia 29 29 29 58 58 58
Chryseobacterium indologenes 1.4 (0.4) 14.5 3.63 3 (1) 14.5 14.5
Corynebacterium xerosis 14.5 29 14.5 29 24.2 (8) 29
Enterococcus faecalis 7.3 29 29 7.3 232 58
Escherichia coli 58 29 29 58 96.7 29
Klebsiella pneumoniae 7.3 29 7.3 7.3 29 12.1 (4)
Micrococcus luteus 7.3 12.1 (4) 7.3 14.5 29 29
Pseudomonas aeruginosa 14.5 48.3 (17) 14.5 58 119.3 58
Serratia marcescens 232 464 232 464 464 464
Staphylococcus aureus 7.3 3.6 7.3 14.5 29 14.5
Staphylococcus capitis 13.3 (3) 24.2 (8) 14.5 29 9.8 29
Staphylococcus caprae 0.9 19.3 (8) 3.6 3.6 29 7.3
Staphylococcus epidermidis 0.9 7.3 3.6 4.2 58 58
Staphylococcus haemolyticus 1.3 (1) 3.6 3.6 3.6 29 38.7 (8)
Staphylococcus lugdunensis 7.3 3.6 1.2 7.3 7.3 7.3
Staphylococcus warneri 1.8 3.6 0.9 1.8 19.3 (8) 14.5
Stenotrophomonas maltophilia 14.5 7.3 14.5 14.5 14.5 14.5
a See Table 1 footnote for explanation of data.
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sient upregulation of efflux pumps may explain the decreases in
the susceptibilities of E. coli, S. epidermidis, S. haemolyticus, and S.
lugdunensis following cetrimide treatment. Furthermore, reduc-
tions in the permeability of the outer membrane have also been
related to reduced microbicide susceptibility in many Gram-neg-
ative bacteria, particularly towardQACs (45) and biguanides (44).
The mechanisms responsible include changes in lipopolysaccha-
ride expression or structure (44), loss of porin proteins (59), and
alterations in outer membrane fatty acid composition (45).
Efflux pump expression also apparently contributes to changes
in biguanide susceptibility in bacteria (60). Fang and colleagues
previously documented the isolation of chlorhexidine-nonsus-
ceptible K. pneumoniae, which expressed a novel locus with a se-
quence compatible to that of a cation efflux pump, designated
cepA (60). S. marcescens isolated from a chlorhexidine-containing
contact lens solution exhibited alterations in outer membrane
protein composition, which was linked to chlorhexidine nonsus-
ceptibility (61). It is also possible that the induction of efflux
mechanismsmay have contributed to the reductions in biguanide
susceptibility observed in the current study.Moore and colleagues
previously examined the effect of sublethal PHMB exposure on a
selection of bacteria isolated from the human skin and a domestic
drain. Similar to our findings, they observed changes in the sus-
ceptibilities of various staphylococcal strains after PHMB expo-
sure (23).
Four species of staphylococci exhibited decreases in apoEdpL-W
susceptibility, three of which were nonreversible. It has been doc-
umented that staphylococci produce extracellular “V8” proteases
that play a role in their pathogenesis (62). Certain cationic pep-
tides are substrates for such proteases and, therefore, when ex-
pressed, confer stable cationic antimicrobial peptide (CAMP) re-
sistance to the bacteria (62). Expression of efflux systems, such as
the qacA-mediated efflux system in S. aureus, has also been asso-
ciatedwithCAMP resistance in staphylococci. Furthermore, it has
been shown that CAMP exposure in certain Gram-negative bac-
teria may induce protein, phospholipid, and lipopolysaccharide
(LPS) modifications due to activation of the PhoP/PhoQ regulon
(63), decreasing the attracting force between the positively
charged peptide and negatively charged bacterial cell wall. In K.
pneumoniae, a bacterial capsular polysaccharide (CPS) is thought
to mediate CAMP resistance (64). K. pneumoniae was one of the
few organisms that showed a widespread decrease in susceptibility
to all the antimicrobials tested in this study. It is therefore plausi-
ble that upregulation of capsule synthesis in K. pneumoniae may
confer a broad-range defense mechanism when antimicrobial
stress is experienced.
As well as showing decreases in competitive fitness (65), bac-
teria adapted to grow in the presence of microbicides can display
further phenotypic alterations such as decreases in growth rate,
pigmentation, and biofilm formation, which could lead to altered
FIG 1 Bacterial biofilm formation before () and after () long-term exposure to ApoEdpL-W (A), chlorhexidine (B), PHMB (C), and triclosan (D). Data
represent changes in biofilm formation in selected bacteria that underwent 4-fold changes in the MBCs following microbicide exposure. *, significant change
in result (P  0.001). Data show the mean levels of biofilm-bound crystal violet for P0 and P10 samples taken from two separate experiments each with three
technical replicates.
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pathogenic capability (30, 65, 66). After exposure to antimicrobi-
als, several bacteria in the current study demonstrated significant
alterations (increases and decreases) in their ability to form bio-
films in a microtiter plate assay. The mechanisms responsible for
such changes and their implications are currently poorly under-
stood, but they may be due to the selection of mutants with alter-
ations in factors directly involved in bacterial adhesion and bio-
film maturation or the selection of isolates with altered growth
rates and fitness, which can indirectly affect biofilm formation
(30, 65). Any adaptation that renders a bacterium less susceptible
to an antimicrobial may therefore also result in reduced or in-
creased fitness (65, 67), which may influence pathogenic ability.
An increased capacity to form biofilms was observed after
apoEdpL-W adaptation in S. epidermidis. While the mechanisms
underlying this change have not been elucidated, a similar effect
observed for S. epidermidis after exposure to alcohol-containing
skin disinfectants was explained on the basis of increased polysac-
charide intracellular adhesin (PIA) synthesis (68). In the current
study, S. marcescens and K. pneumoniae also exhibited increased
biofilm-forming abilities after chlorhexidine exposure, which
could potentially be mediated through altered capsule formation
in K. pneumoniae (64, 69) or the upregulation of efflux pumps
(60).
Decreases in bacterial specific growth rates have been reported
following sublethal exposure to antimicrobials, and such changes
may have influenced biofilm formation in our bacterial isolates
(30, 70). The apparent decreases in biofilm formation observed
for E. faecalis after apoEdpL-W exposure and B. cepacia after ex-
posure to chlorhexidine may result from a lower density of cells
within a slower growing culture, which could influence the ex-
pression of cell density-dependent genes involved in the process of
biofilm formation (71). S. aureus and S. lugdunensis showed a
decrease in biofilm formation after triclosan exposure. A decrease
in staphylococcal biofilm production has previously been attrib-
uted to alterations in PIA and Agrocybe aegerita peroxidase (Aap)
production or to changes in sarA, a regulatory genewhich controls
the expression of virulence determinants involved in biofilm de-
velopment, such as DNase (72).
In conclusion, repeated exposure of bacteria to certain micro-
bicides in vitro can result in decreases in antimicrobial suscepti-
bility that may be transient or sustained, probably resulting from
temporary phenotypic adaptations or the selection of stable ge-
netic mutations, respectively. In adapting to antimicrobial stress,
bacteria can exhibit alterations in other physiological characteris-
tics, such as increases or decreases in biofilm-forming ability.
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